BioXcel Therapeutics's top three insider shareholders as of April 17, 2026 are Vimal Mehta (Ceo And President, 7.69Mn shares), Vimal Mehta (Ceo And President, 21.26K shares), David J. Mack (Director, 20.32K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Vimal Mehta | Ceo And President | 0 | 7,685,501 | 06 Jun, 2024 |
| Vimal Mehta | Ceo And President | 21,259 | 0 | 16 Mar, 2026 |
| David J. Mack | - | 20,317 | 0 | 03 Nov, 2025 |
| Vincent O'Neill | Chief Medical Officer | 19,957 | 0 | 17 Dec, 2024 |
| Matthew T. Wiley | Chief Commercial Officer | 19,011 | 0 | 03 Oct, 2024 |
| Javier Rodriguez | - | 6,863 | 0 | 16 Mar, 2026 |
| Richard I Steinhart | Chief Financial Officer | 6,645 | 0 | 16 Mar, 2026 |
| Frank Yocca | Chief Scientific Officer | 6,520 | 0 | 16 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 14 Mar, 2026 | Vimal Mehta | Common Stock | A | 164 | - | 21,040 | D | M |
| 14 Mar, 2026 | Frank Yocca | Common Stock | A | 33 | - | 6,485 | D | M |
| 14 Mar, 2026 | Richard I Steinhart | Common Stock | A | 33 | - | 6,610 | D | M |
| 14 Mar, 2026 | Javier Rodriguez | Common Stock | A | 33 | - | 6,828 | D | M |
| 15 Mar, 2026 | Vimal Mehta | Common Stock | A | 219 | - | 21,259 | D | M |
| 15 Mar, 2026 | Richard I Steinhart | Common Stock | A | 35 | - | 6,645 | D | M |
| 15 Mar, 2026 | Frank Yocca | Common Stock | A | 35 | - | 6,520 | D | M |
| 15 Mar, 2026 | Javier Rodriguez | Common Stock | A | 35 | - | 6,863 | D | M |
| 14 Mar, 2026 | Richard I Steinhart | Restricted Stock Units | D | 33 | $0.00 | 97 | D | M |
| 14 Mar, 2026 | Javier Rodriguez | Restricted Stock Units | D | 33 | $0.00 | 97 | D | M |
| 14 Mar, 2026 | Frank Yocca | Restricted Stock Units | D | 33 | $0.00 | 97 | D | M |
| 15 Mar, 2026 | Frank Yocca | Restricted Stock Units | D | 35 | $0.00 | 247 | D | M |
| 15 Mar, 2026 | Richard I Steinhart | Restricted Stock Units | D | 35 | $0.00 | 247 | D | M |
| 15 Mar, 2026 | Javier Rodriguez | Restricted Stock Units | D | 35 | $0.00 | 247 | D | M |
| 14 Mar, 2026 | Vimal Mehta | Restricted Stock Units | D | 164 | $0.00 | 488 | D | M |
| 15 Mar, 2026 | Vimal Mehta | Restricted Stock Units | D | 219 | $0.00 | 1,532 | D | M |
| 09 Jan, 2026 | Sandeep Laumas | Stock Option (Right to Buy) | A | 17,000 | $0.00 | 17,000 | D | A |
| 09 Jan, 2026 | Rajiv Patni | Stock Option (Right to Buy) | A | 17,000 | $0.00 | 17,000 | D | A |
| 09 Jan, 2026 | Michal Votruba | Stock Option (Right to Buy) | A | 17,000 | $0.00 | 17,000 | D | A |
| 09 Jan, 2026 | June Bray | Stock Option (Right to Buy) | A | 17,000 | $0.00 | 17,000 | D | A |